News / USA

Researcher Blueprints Ovarian Cancer Tumors

Laura Shawver fights to change one-size-fits-all approach to treatment

Clearity Foundation founder Laura Shawver finishes a charity run for molecular profiling of ovarian cancer patients.
Clearity Foundation founder Laura Shawver finishes a charity run for molecular profiling of ovarian cancer patients.

Multimedia

Audio
Rosanne Skirble

Ovarian cancer is called a “silent killer” because by the time symptoms appear and diagnosis is made, it is generally too late for a cure.



Last year, 22,000 women were diagnosed with the disease in the United States; 14,000 of them died.

Laura Shawver, a scientist cancer researcher and commercial drug developer, is fighting back by offering ovarian cancer patients a molecular profile or blueprint of their tumor.  

Shawver, a cancer survivor who has been in remission since 2006, had the same initial treatment as every ovarian cancer patient.

“The the same treatment that’s been around for at least 30 years," she says. "We all get surgery and we all get chemotherapy. Most people have a response, and we think we’re cured.”

Shawver is one of the few lucky ones. Ovarian cancer returns in 75 percent of  patients.

“When we recur that’s when the guesswork comes in.” Shawver says that’s because ovarian tumors differ so widely from each other and respond differently to drugs. So, women end up going through round after round of different chemotherapy drugs. “It’s a random selection and, unfortunately, that means that the patient frequently gets toxicity without benefit.”  

That has been Sheila Connor’s experience. She was diagnosed with late-stage ovarian cancer in 2007. After initial surgery and chemotherapy, the cancer returned four times over four years.

“The longest remission I had was about eight months,” says Connor.

Sheila Connor, who has lived with ovarian cancer since 2007, has opted to leave treatment.
Sheila Connor, who has lived with ovarian cancer since 2007, has opted to leave treatment.

She tried a battery of drugs. One would work for a time. Another would complicate her illness. “All the skin on my hands and feet peeled off, and I had mouth sores from it that I had to be hospitalized because I couldn’t eat. I couldn’t eat anything without pain medicine.”

Connor recently left a clinical trial because her cancer had progressed. She's decided to stop treatment.

Shawver believes the one-size-fits-all treatment approach doesn’t work. “There’s probably a better choice when they recur - and the chemo agents that are available, the molecular targeted agents that are available, the clinical trials that are available - should all be taken into consideration when faced with recurrent disease.”

In 2007, Shawver started the Clearity Foundation. The nonprofit offers ovarian cancer patients a molecular profile, or blueprint, of their tumor. That helps target drug therapy to a specific tumor.

Profiles are available for other cancers, but this is the first time it’s being applied to ovarian cancer.

Clearity compares the diseased ovarian tumor to others in its database. That suggests which of the dozen or so drugs regularly used for ovarian cancer might be most effective, based on their success in similar cases.

The foundation also screens for biological markers, which can indicate how a tumor will respond to certain chemotherapy agents. This opens options to try other cancer-fighting drugs.

That profiling wasn’t available when Sheila Connor's cancer first recurred. She says it’s a tool that can help patients make informed decisions. “If you had some idea, whether you would respond to these drugs you could try something else, try another standard drug and then if the other standard drugs don’t work, then I know that I need to get on a clinical trial.”

That is how Shawver is determined to change the way ovarian cancer is treated: one patient at a time. “In order to for the paradigm to really shift, we need for every woman who has recurring ovarian cancer to be willing to get her tumor profiled, to be willing to get on the right clinical trial and to really educate themselves about what are the treatment options.”

Shawver says this approach not only improves the quality of life for women with recurring ovarian cancer, it can also lead to the development of specific new drugs for the often deadly disease.

You May Like

Myanmar Fighting Poses Dilemma for China

To gain some insight into conflict, VOA’s Steve Herman spoke with Min Zaw Oo, director of ceasefire negotiation and implementation at Myanmar Peace Center More

Australia Concerned Over Islamic State 'Brides'

Canberra believes there are between 30 and 40 Australian women who have taken part in terror attacks or are supporting the Islamic State terror network More

Recreational Marijuana Use Now Legal in Washington, DC

Law allows adults 21 and over to privately possess and smoke 0.05 kilogram of pot, and to grow small amounts of the plant More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
US Supreme Court Hears Hijab Discrimination Casei
X
Katherine Gypson
February 25, 2015 11:30 PM
The U.S. Supreme Court has heard opening arguments in a workplace religious discrimination case that examines whether a clothing store can refuse to hire a young woman for wearing the headscarf she says is a symbol of her Muslim faith. Katherine Gypson reports from the Supreme Court.
Video

Video US Supreme Court Hears Hijab Discrimination Case

The U.S. Supreme Court has heard opening arguments in a workplace religious discrimination case that examines whether a clothing store can refuse to hire a young woman for wearing the headscarf she says is a symbol of her Muslim faith. Katherine Gypson reports from the Supreme Court.
Video

Video Falling Gas Prices Hurt Nascent Illinois Hydraulic Fracturing Industry

Falling oil prices are helping consumers purchase cheaper petroleum at the pump. But that’s made hydraulic fracturing or “fracking” less economically viable for the companies in the United States invested in the process. VOA’s Kane Farabaugh reports on one Midwestern town that was hoping to change its fortunes by cashing in on the next big U.S. oil boom.
Video

Video Fighting in Sudan's South Kordofan Fuels Mass Displacement

Heavy fighting in Sudan's South Kordofan state is causing hundreds of thousands to flee into uncertain conditions. Local aid organizations estimate as many as 400,000 civilians have been internally displaced since the conflict began more than three years ago, while another 250,000 have fled across the border to refugee camps in South Sudan. VOA's Adam Bailes reports.
Video

Video Lao Dam Project Runs Into Opposition

A Lao dam project on a section of the Mekong River is drawing opposition from local fishermen, international environmental groups and neighboring countries. VOA's Say Mony visited the region to investigate the concerns. Colin Lovett narrates.
Video

Video A Filmmaker Discovers Her Biracial Identity in "Little White Lie

Lacey Schwartz grew up in an upper middle-class Jewish family, in a town in upstate New York where almost everyone she knew was white. She assumed that she was, as well. Her recent documentary, Little White Lie, tells the story of how she uncovered the secret of her true racial background. VOA’s Carolyn Weaver has more on the film.
Video

Video Deep Under Antarctic Ice Sheet, Life!

With the end of summer in the Southern hemisphere, the Antarctic research season is over. Scientists from Northern Illinois University are back in their laboratory after a 3-month expedition on the Ross Ice Shelf, the world’s largest floating ice sheet. As VOA’s Rosanne Skirble reports, they hope to find clues to explain the dynamics of the rapidly melting ice and its impact on sea level rise.
Video

Video US-Cuba Normalization Talks Resume Friday

Negotiations aimed at normalizing diplomatic relations between the U.S. and Cuba resume Friday. On the table: lifting a half-century trade embargo and easing banking and travel restrictions. There's opposition in Congress, but some analysts say there may be sufficient political and economic incentives in both nations for a potential breakthrough this year. VOA's Mil Arcega reports.
Video

Video Pakistan's Deadline For SIM Registration Has Cellphone Users Scrambling

Pakistani cell phone users have until midnight Thursday to register their SIM cards, or their service will be cut off. While some privacy experts worry about government intrusion, many Pakistanis are just worried about keeping their phone lines open. VOA Deewa reporter Arshad Muhmand has more from Peshawar.
Video

Video Myanmar Warns Factory Workers to End Strikes

Outside Myanmar's main city Yangon, thousands of workers walked off their jobs earlier this month demanding a doubling of their wages, pay raises after a year and input from labor unions on industrial regulations. Since Friday, the standoff has grown more tense as police moved in to disrupt the sit-ins, resulting in clashes that injured people from both sides. VOA correspondent Steve Herman visited industrial zones which have become a focus of Myanmar's fledgling workers rights movement.
Video

Video Oscar Winners Do More Than Thank the Academy

The Academy Awards presentation is Hollywood’s night to reward the best movies from the previous year. It’s typically a lot of glitter, a lot of thank you’s, a lot of speeches. But many of this year’s speeches carried messages beyond the thank you's. VOA’s Carolyn Presutti takes a look.

All About America

Circumventing Censorship

An Internet Primer for Healthy Web Habits

As surveillance and censoring technologies advance, so, too, do new tools for your computer or mobile device that help protect your privacy and break through Internet censorship.
More